Bharat Biotech

Bharat Biotech To Conduct Covaxin Trial On Age Group Between 2 To 18, DCGI Gives Nod

The Drug Controller General of India on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children between the age group of 2…

View Post

Bharat Biotech’s Covaxin Gets Approval For Phase 2/3 Trials On 2-18 Year-Olds

According to official sources, Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years.…

View Post

Modi Govt Asks Serum Institute, Bharat Biotech To Lower Price Of Covishield And Covaxin

The central government on Monday asked the Serum Institute and Bharat Biotech to lower the price of their COVID-19 vaccines amid criticism from various states who accused the companies of…

View Post

Bharat Biotech Seeks DCGI’s Nod To Extend Shelf Life Of Covaxin

Bharat Biotech has written to the India’s drug regulator seeking an extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on…

View Post

Covaxin Demonstrates 100% Efficacy Against Severe Covid-19, Reveals Phase 3 Interim Analysis

Bharat Biotech announced the second Interim results from Phase 3 trials on Wednesday. The interim analysis was based on accruing more than 87 symptomatic cases of Covid-19. Bharat Biotech and…

View Post

Half A Dozen More Vaccines Will Be Introduced Soon To Fight Covid-19: Dr Harsh Vardhan

Union minister of health and family welfare, Dr Harsh Vardhan has announced that six more vaccines against Covid-19 will be introduced soon. “Six to eight months ago, lack of testing…

View Post

Subject Expert Committee (SEC) Recommends Dropping ‘Clinical Trial Mode’ Tag For Covaxin

The drug regulator’s subject expert committee (SEC) has recommended doing away with the “clinical trial mode” for Bharat Biotech’s anti-Covid vaccine Covaxin. It has recommended that vaccine should be used for regular…

View Post

Menu

Bharat Biotech

Bharat Biotech To Conduct Covaxin Trial On Age Group Between 2 To 18, DCGI Gives Nod

Bharat Biotech’s Covaxin Gets Approval For Phase 2/3 Trials On 2-18 Year-Olds

Modi Govt Asks Serum Institute, Bharat Biotech To Lower Price Of Covishield And Covaxin

Bharat Biotech Seeks DCGI’s Nod To Extend Shelf Life Of Covaxin

Covaxin Demonstrates 100% Efficacy Against Severe Covid-19, Reveals Phase 3 Interim Analysis

Half A Dozen More Vaccines Will Be Introduced Soon To Fight Covid-19: Dr Harsh Vardhan

Subject Expert Committee (SEC) Recommends Dropping ‘Clinical Trial Mode’ Tag For Covaxin

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report